Matouš Hrdinka

1.5k total citations
34 papers, 1.0k citations indexed

About

Matouš Hrdinka is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Matouš Hrdinka has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Immunology and 7 papers in Oncology. Recurrent topics in Matouš Hrdinka's work include Immune Cell Function and Interaction (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Ubiquitin and proteasome pathways (6 papers). Matouš Hrdinka is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Ubiquitin and proteasome pathways (6 papers). Matouš Hrdinka collaborates with scholars based in Czechia, United Kingdom and United States. Matouš Hrdinka's co-authors include Mads Gyrd‐Hansen, Václav Hořejšı́, Monica Yabal, Roman Hájek, Tomáš Jelı́nek, Michal Šimíček, Berthe Katrine Fiil, P.R. Elliott, David Komander and Katrin Bagola and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Matouš Hrdinka

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by Matouš Hrdinka

Since Specialization

Citations

This map shows the geographic impact of Matouš Hrdinka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matouš Hrdinka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matouš Hrdinka more than expected).

Fields of papers citing papers by Matouš Hrdinka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matouš Hrdinka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matouš Hrdinka. The network helps show where Matouš Hrdinka may publish in the future.

Co-authorship network of co-authors of Matouš Hrdinka

This figure shows the co-authorship network connecting the top 25 collaborators of Matouš Hrdinka. A scholar is included among the top collaborators of Matouš Hrdinka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matouš Hrdinka. Matouš Hrdinka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential 2025 ·Biomarker Research ·(unknown), (unknown), Zuzana Chyra, Sabina Ševčı́ková, (unknown), Tomáš Jelı́nek, Roman Hájek, Matouš Hrdinka	0
2	Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors 2024 ·Leukemia ·Tomáš Jelı́nek, David Žihala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Serafim Nenarokov, (unknown), (unknown), (unknown), Jan Vrána, (unknown), (unknown), (unknown), Matouš Hrdinka, Zuzana Chyra, Giovanni Stracquadanio, (unknown), Roman Hájek	17
3	Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), David Žihala, (unknown), Alexander Vdovin, (unknown), Tereza Ševčíková, Zuzana Chyra, Tomáš Jelı́nek, Michal Šimíček, Annamaria Gullà, Kenneth C. Anderson, Roman Hájek, Matouš Hrdinka	11
4	The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma 2022 ·Nature Communications ·Alexander Vdovin, Tomáš Jelı́nek, David Žihala, Tereza Ševčíková, (unknown), (unknown), (unknown), (unknown), (unknown), Zuzana Chyra, (unknown), (unknown), Matouš Hrdinka, Roman Hájek, Michal Šimíček	16
5	Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment 2021 ·Cells ·(unknown), (unknown), (unknown), Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giebel, Michal Šimíček, Tomáš Jelı́nek, Tereza Ševčíková, (unknown), Zdeněk Kořı́stek, Roman Hájek, Juli R. Bagó	12
6	The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation 2017 ·Molecular Cell ·Matouš Hrdinka, Mads Gyrd‐Hansen	96
7	Synaptonuclear messenger PRR 7 inhibits c‐Jun ubiquitination and regulates NMDA ‐mediated excitotoxicity 2016 ·The EMBO Journal ·(unknown), Anna Karpova, Matouš Hrdinka, Jeffrey Lopez‐Rojas, Sanda Iacobaş, (unknown), Dumitru A. Iacobaş, Michael R. Kreutz, Bryen A. Jordan	28
8	CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling 2016 ·Cell Reports ·Matouš Hrdinka, Berthe Katrine Fiil, (unknown), (unknown), Katrin Bagola, Monica Yabal, P.R. Elliott, Rune Busk Damgaard, David Komander, Philipp J. Jost, Mads Gyrd‐Hansen	119
9	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling 2016 ·Molecular Cell ·P.R. Elliott, (unknown), Matouš Hrdinka, Katrin Bagola, Berthe Katrine Fiil, Stephen H. McLaughlin, Jane L. Wagstaff, Norbert Volkmar, John C. Christianson, Benedikt M. Kessler, Stefan M.V. Freund, David Komander, Mads Gyrd‐Hansen	121
10	Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice 2016 ·PLoS ONE ·Matouš Hrdinka, (unknown), (unknown), Ales Drobek, Ondřej Štěpánek, Dirk Schlüter, Dirk Reinhold, Bryen A. Jordan, (unknown), Burkhart Schraven, Michael R. Kreutz	3
11	Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors 2015 ·Chemistry & Biology ·Peter Canning, (unknown), Tobias Schwerd, Matouš Hrdinka, Jenny L. Maki, Danish Saleh, Chalada Suebsuwong, Soumya S. Ray, Paul E. Brennan, Gregory D. Cuny, Holm H. Uhlig, Mads Gyrd‐Hansen, Alexei Degterev, Alex N. Bullock	77
12	Membrane microdomains in immunoreceptor signaling 2014 ·FEBS Letters ·Václav Hořejšı́, Matouš Hrdinka	42
13	PAG - a multipurpose transmembrane adaptor protein 2013 ·Oncogene ·Matouš Hrdinka, (unknown)	39
14	LST1/A Is a Myeloid Leukocyte-specific Transmembrane Adaptor Protein Recruiting Protein Tyrosine Phosphatases SHP-1 and SHP-2 to the Plasma Membrane 2012 ·Journal of Biological Chemistry ·Peter Dráber, Ondřej Štěpánek, Matouš Hrdinka, Ales Drobek, Lukáš Chmátal, (unknown), Tereza Ormsby, Pavla Angelisová, Václav Hořejšı́, Tomáš Brdička	22
15	The Transmembrane Region Is Responsible for Targeting of Adaptor Protein LAX into “Heavy Rafts” 2012 ·PLoS ONE ·Matouš Hrdinka, Pavel Otáhal, Václav Hořejšı́	5
16	PRR7 Is a Transmembrane Adaptor Protein Expressed in Activated T Cells Involved in Regulation of T Cell Receptor Signaling and Apoptosis 2011 ·Journal of Biological Chemistry ·Matouš Hrdinka, Peter Dráber, Ondřej Štěpánek, Tereza Ormsby, Pavel Otáhal, Pavla Angelisová, Tomáš Brdička, Jan Pačes, Václav Hořejšı́, Karel Drbal	11
17	A New Type of Membrane Raft-Like Microdomains and Their Possible Involvement in TCR Signaling 2010 ·The Journal of Immunology ·Pavel Otáhal, Pavla Angelisová, Matouš Hrdinka, Tomáš Brdička, Petr Novák, Karel Drbal, Václav Hořejšı́	32
18	Acute intermittent porphyria – impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties 2009 ·FEBS Journal ·(unknown), Matouš Hrdinka, Vladimı́r Saudek, Pavel Martásek	13
19	May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria. Comparison with the situation in Slavic population 2006 ·Physiological Research ·Matouš Hrdinka, Hervé Puy, Pavel Martásek	27
20	De novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: Molecular biochemical study 2006 ·Physiological Research ·(unknown), (unknown), Matouš Hrdinka, (unknown), (unknown), C.S. Raman, Pavel Martásek	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact